Skip to main content
OpenTrials

Clinical trial condition

Hemophilia A

Explore clinical trials studying Hemophilia A. Study availability and eligibility vary by location and protocol.

281 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia A trial results

Completed

An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A

NCT02172950

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Study Site 8400213 San Diego, California, United States
  • Study Site 8400241 Aurora, Colorado, United States
  • Study Site 8400118 Hartford, Connecticut, United States
  • Study Site 8400116 Miami, Florida, United States
View all 64 locations
View Trial Details
Completed

Global Epidemiologic Study of Preexisting Immunity to AAV in Adults With Severe Hemophilia

NCT03185897

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Orthopaedic Hemophilia Treatment Center Los Angeles, California, United States
  • University of Colorado Hemophilia & Thrombosis Center Aurora, Colorado, United States
  • Michigan State University East Lansing, Michigan, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View all 23 locations
View Trial Details
Completed

Non-interventional Post-authorisation Study to Document the Immunogenicity, Safety, and Efficacy of NUWIQ

NCT02962765

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • University of Florida Gainesville, Florida, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
  • Tulane University New Orleans, Louisiana, United States
  • Hemophilia Treatment Center of Nevada Las Vegas, Nevada, United States
View all 39 locations
View Trial Details
Completed

Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia

NCT04072237

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +12 more
Locations
  • Medical Center "Hippocrates - N" Plovdiv, Bulgaria
  • Specialized Hospital for Active Treatment of Hematological Diseases Sofia, Bulgaria
  • Kirov Research Institute of Hematology and Blood Transfusion Kirov, Russia
  • National Medical Hematology Research Center Moscow, Russia
View Trial Details
Completed

Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901

NCT00157053

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Mountain States Regional Hemophilia and Thrombosis Center Aurora, Colorado, United States
  • Childrens Healthcare of Atlanta Blood Bank Atlanta, Georgia, United States
  • Comprehensive Bleeding Disorders Center Peoria, Illinois, United States
  • Indiana Hemophilia & Thrombosis Center Indianapolis, Indiana, United States
View all 24 locations
View Trial Details
Completed

Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery

NCT00157105

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Children´s Hospital Los Angeles, Hemophilia Comprehensive Care Center, Division of Pediatric Hematology/Oncology Los Angeles, California, United States
  • Children´s Healthcare of Atlanta Blood Bank Atlanta, Georgia, United States
  • Indiana Hemophilia & Thrombosis Center Indianapolis, Indiana, United States
  • University of Iowa Hospitals and Clinics, Iowa Regional Hemophilia Center, Department of Pediatrics Iowa City, Iowa, United States
View Trial Details
Completed

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors

NCT02622321

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Santa Monica Oncology Center Santa Monica, California, United States
  • University of Colorado Denver, Children's Hospital Aurora, Colorado, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
View all 44 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of Prophylactic Emicizumab in Hemophilia A Patients With Inhibitors

NCT03191799

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Royal Prince Alfred Hospital; Haematology Camperdown, New South Wales, Australia
  • Alfred Hospital Melbourne, Victoria, Australia
  • Fiona Stanley Hospital Murdoch, Western Australia, Australia
  • UZ Leuven Gasthuisberg Leuven, Belgium
View all 72 locations
View Trial Details
Completed

A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors

NCT02795767

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of Colorado Denver, Children's Hospital Aurora, Colorado, United States
  • Children'S Healthcare of Atlanta Atlanta, Georgia, United States
  • Rush Medical Center Chicago, Illinois, United States
View all 28 locations
View Trial Details

Related conditions